Peroxiredoxin 6 Protects Pulmonary Epithelial Cells from Cigarette-related Ferroptosis in Chronic Obstructive Pulmonary Disease

Tingting Wei,Xiaocen Wang,Ke Lang,Yansha Song,Jinlong Luo,Zhaolin Gu,Dong Yang,Yuanlin Song
DOI: https://doi.org/10.1007/s10753-024-02077-4
2024-01-01
Inflammation
Abstract:Peroxiredoxin 6 (PRDX6) has a protective effect on pulmonary epithelial cells against cigarette smoke (CS)-induced ferroptosis. This study investigates the role of PRDX6 in the development of chronic obstructive pulmonary disease (COPD) and its possibility as a target. We observed that PRDX6 was downregulated in lung tissues of COPD patients and in CS-stimulated cells. The degradation of PRDX6 could be through the lysosomal pathway. PRDX6 deficiency exacerbated pulmonary inflammation and mucus hypersecretion in vivo. Overexpression of PRDX6 in Beas-2B cells ameliorated CS-induced cell death and inflammation, suggesting its protective role against CS-induced damage. Furthermore, PRDX6 deficiency promoted ferroptosis by adding the content of iron and reactive oxygen species, while iron chelation with deferoxamine mitigated CS-induced ferroptosis, cell death, and inflammatory infiltration both in vitro and in vivo. The critical role of PRDX6 in regulating ferroptosis suggests that targeting PRDX6 or iron metabolism may represent a promising strategy for COPD treatment.
What problem does this paper attempt to address?